MERLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 616
EU - Europa 397
AS - Asia 371
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.386
Nazione #
US - Stati Uniti d'America 607
CN - Cina 299
IE - Irlanda 177
FI - Finlandia 68
SG - Singapore 45
UA - Ucraina 35
DE - Germania 31
IT - Italia 29
IN - India 21
SE - Svezia 19
GB - Regno Unito 14
FR - Francia 11
CA - Canada 9
BE - Belgio 4
JP - Giappone 3
LT - Lituania 2
RU - Federazione Russa 2
TR - Turchia 2
AU - Australia 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
Totale 1.386
Città #
Dublin 174
Chandler 151
Nanjing 71
Jacksonville 64
Beijing 55
Boardman 46
Ashburn 43
Singapore 38
Helsinki 32
Nanchang 31
Ann Arbor 26
Princeton 25
Wilmington 25
Lawrence 24
Changsha 23
Shanghai 22
Pune 20
Medford 16
Shenyang 16
Hebei 15
Jiaxing 14
New York 14
Tianjin 13
Los Angeles 12
Milan 9
Woodbridge 8
Pavia 7
Toronto 6
Brussels 4
Falkenstein 4
Hangzhou 4
Norwalk 4
Cork 3
Guangzhou 3
Tokyo 3
Zhengzhou 3
Fairfield 2
Houston 2
Jinan 2
Lanzhou 2
Ningbo 2
Paris 2
San Francisco 2
Seattle 2
Washington 2
Wuhan 2
Athens 1
Auburn Hills 1
Baoding 1
Baotou 1
Canberra 1
Chengdu 1
Clifton 1
Dalian 1
Dearborn 1
Des Moines 1
Kunming 1
London 1
Luoyang 1
Markham 1
Monmouth Junction 1
Olomouc 1
Oslo 1
Ottawa 1
Redwood City 1
Saint Petersburg 1
San Jose 1
Santa Clara 1
Targu 1
Tomsk 1
Verona 1
Weinan 1
Xiangtan 1
Zhoukou 1
Totale 1.076
Nome #
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 96
High resolution genome-wide array-comparative genomic hybridization in splenic marginal zone B-cell lymphoma 75
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 73
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. 69
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 69
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma. 67
Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia 60
Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin's lymphoma 59
Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy 58
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms 57
Everolimus in diffuse large B-cell lymphomas 56
The NOTCH pathway is recurrently mutated in diffuse large B cell lymphoma associated with hepatitis C virus infection. 56
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi. 55
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi. 55
Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas 55
Antiviral therapies for managing viral hepatitis in lymphoma patients 54
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 53
Splenic marginal zone lymphoma: clinical clustering of immunoglobulin heavy chain repertoires 52
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders 51
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project. 50
Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients 48
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. 37
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project. 32
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi 26
null 21
Rituximab maintenance in follicular lymphoma patients 20
Pre-Treatment with Bendamustine Does Not Affect Stem Cell Mobilization in Patients with Indolent Non-Hodgkin Lymphomas: A Multicenter Study on Behalf of the Fondazione Italiana Linfomi 18
T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms 16
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi 10
Totale 1.448
Categoria #
all - tutte 6.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.919


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202092 0 0 0 0 0 7 6 14 6 43 15 1
2020/2021104 10 7 2 8 7 8 1 20 15 14 9 3
2021/2022103 3 2 4 0 5 1 0 9 4 1 16 58
2022/2023441 37 44 5 26 43 37 0 19 204 1 15 10
2023/2024220 19 40 10 12 13 62 4 15 2 12 17 14
2024/2025123 11 32 15 5 10 50 0 0 0 0 0 0
Totale 1.448